| Literature DB >> 34831997 |
Sandra Rierola-Fochs1, Luz Adriana Varela-Vásquez1, Jose Antonio Merchán-Baeza1, Eduard Minobes-Molina1.
Abstract
BACKGROUND: Phantom limb pain can be defined as discomfort or pain in a missing part of the limb. The aims of this study were to develop and validate, through a Delphi methodology, a graded motor imagery protocol in order to reduce phantom limb pain.Entities:
Keywords: amputee; graded motor imagery; pain; phantom limb; treatment
Mesh:
Year: 2021 PMID: 34831997 PMCID: PMC8623973 DOI: 10.3390/ijerph182212240
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Study flow and objectives.
Values used to assess the argumentation coefficient (Ka) [29].
| High | Medium | Low | |
|---|---|---|---|
| Theoretical analysis performed by the expert | 0.3 | 0.2 | 0.1 |
| Experience gained | 0.5 | 0.4 | 0.2 |
| Studies on the subject by Spanish authors | 0.05 | 0.05 | 0.05 |
| Studies on the subject by international authors | 0.05 | 0.05 | 0.05 |
| Own knowledge | 0.05 | 0.05 | 0.05 |
| Expert intuition | 0.05 | 0.05 | 0.05 |
Kappa index rating (K).
| Value of K | Strength of Concordance |
|---|---|
| <0.20 | Poor |
| 0.21–0.40 | Weak |
| 0.41–0.60 | Moderate |
| 0.61–0.80 | Good |
| 0.81–1.00 | Very good |
Values obtained in each of the participants.
| Participant | Kc | Ka | K |
|---|---|---|---|
| 1 | 0.7 | 0.9 | 0.80 medium |
| 2 | 0.8 | 0.9 | 0.85 high |
| 3 | 1 | 0.9 | 0.95 high |
| 4 | 0.8 | 1 | 0.90 high |
| 5 | 0.7 | 0.9 | 0.8 medium |
| 6 | 0.7 | 0.9 | 0.8 medium |
| 7 | 0.7 | 0.9 | 0.8 medium |
| 8 | 0.9 | 0.8 | 0.85 high |
| 9 | 0.8 | 0.8 | 0.8 medium |
| 10 | 0.7 | 0.9 | 0.8 medium |
| 11 | 0.7 | 0.8 | 0.75 medium |
| 12 | 0.7 | 0.8 | 0.75 medium |
| 13 | 0.7 | 0.9 | 0.80 medium |
| 14 | 0.9 | 1 | 0.95 high |
| 15 | 0.7 | 0.9 | 0.80 medium |
| Mean | 0.77 | 0.89 | 0.83 high |
Kc: knowledge coefficient Ka: argumentation coefficient K: coefficient of expert competence.
Laterality recognition.
| R1 Intensity | R2 Intensity | R1 Frequency | R2 Frequency | R1 Duration | R2 Duration | R1 Progression | R2 Progression | |
|---|---|---|---|---|---|---|---|---|
| Mean | 6.16 | 6.53 | 5.84 | 6.46 | 6.5 | - | 6.69 | - |
| Median | 6 | 7 | 7 | 7 | 7 | - | 7 | - |
| Maximum | 7 | 7 | 7 | 7 | 7 | - | 7 | - |
| Minimum | 4 | 6 | 2 | 3 | 4 | - | 6 | - |
| Standard deviation | 0.89 | 0.52 | 1.72 | 1.09 | 0.87 | - | 0.48 | - |
| Quartile 1 | 6 | 6 | 6 | 6 | 6 | - | 6 | - |
| Quartile 3 | 7 | 7 | 7 | 7 | 7 | - | 7 | - |
| IQR | 1 | 1 | 1 | 1 | 1 | - | 1 | - |
| RIR (%) | 16.6% | 14.28% | 14.28% | 14.28% | 14.28% | - | 14.28% | - |
R1: Round 1; R2: Round 2; IQR: Interquartile range; RIR: Relative interquartile range; -: Validated in the first round.
Motor imagery.
| R1 Intensity | R2 Intensity | R1 Frequency | R2 Frequency | R1 Duration | R2 Duration | R1 Progression | R2 Progression | |
|---|---|---|---|---|---|---|---|---|
| Mean | 6.07 | 6.77 | 6.07 | 6.54 | 6.7 | - | 6.7 | - |
| Median | 6 | 7 | 6 | 7 | 7 | - | 7 | - |
| Maximum | 7 | 7 | 7 | 7 | 7 | - | 7 | - |
| Minimum | 3 | 6 | 3 | 4 | 6 | - | 6 | - |
| Standard deviation | 1.18 | 0.44 | 1.18 | 0.88 | 0.63 | - | 0.63 | - |
| Quartile 1 | 6 | 7 | 6 | 7 | 7 | - | 7 | - |
| Quartile 3 | 7 | 7 | 7 | 7 | 7 | - | 7 | - |
| IQR | 1 | 0 | 1 | 1 | 0 | - | 0 | - |
| RIR (%) | 16.6% | 0% | 16.6% | 14.28% | 0% | - | 0% | - |
R1: Round 1; R2: Round 2; IQR: Interquartile range; RIR: Relative interquartile range; -: Validated in the first round.
Mirror therapy.
| R1 Intensity | R2 Intensity | R1 Frequency | R2 Frequency | R1 Duration | R2 Duration | R1 Progression | R2 Progression | |
|---|---|---|---|---|---|---|---|---|
| Mean | 6.15 | 6.77 | 6.4 | - | 6.7 | - | 6.7 | - |
| Median | 7 | 7 | 7 | - | 7 | - | 7 | - |
| Maximum | 7 | 7 | 7 | - | 7 | - | 7 | - |
| Minimum | 3 | 4 | 4 | - | 6 | - | 5 | - |
| Standard deviation | 1.34 | 0.44 | 0.96 | - | 0.48 | - | 0.64 | - |
| Quartile 1 | 6 | 7 | 6 | - | 6 | - | 7 | - |
| Quartile 3 | 7 | 7 | 7 | - | 7 | - | 7 | - |
| IQR | 1 | 1 | 1 | - | 1 | - | 0 | - |
| RIR (%) | 14.28% | 14.28% | 14.28% | - | 14.28% | - | 0% | - |
R1: Round 1; R2: Round 2; IQR: Interquartile range; RIR: Relative interquartile range; -: Validated in the first round.
Figure 2Sequence and progression of the intervention.